New Progress in Prevention and Personalized Treatment for Cardiovascular Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 10 December 2024 | Viewed by 78
Special Issue Editor
Interests: COPD; hypertension; heart failure; multimorbidity; vascular medicine; lifestyle changes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The term “personalized medicine” was first introduced in the late 1990s, referring to “the tailoring of medical treatment to the individual characteristics of each patient”. This paradigm shift highlighted the need to classify each patient as a unique individual, phenotyping their susceptibility to a particular disease or their response to a particular treatment. This approach offers several benefits: better choice of drugs; improved treatment selection in multimorbid patients; safer dosing options; reduced healthcare costs by avoiding multiple assessments; fewer inappropriate laboratory and diagnostic tests; improved patient perceived quality of life and level of support. Cardiovascular disease is one of the better areas where personalized medicine can make a difference in how patients are approached and treated. It is a leading cause of death worldwide and a major area of research and therapeutic interest. In cardiovascular medicine, especially in elderly multimorbid subjects, it is important to treat the patient and not the disease, and several new areas of development are underway. The aim of this Special Issue is to welcome both original research and review articles that provide new contributions to this important topic.
Dr. Domenico Di Raimondo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vascular medicine
- hypertension
- heart failure
- multimorbidity
- lifestyle changes
- venous thromboembolic disease (VTE)
- cardiovascular risk
- chronic coronary artery disease
- cardiovascular therapy
- atherosclerosis
- systemic inflammation
